NCT06059625 is a NA clinical trial of rotatori cuff repair in Cuff Injury, Rotator, sponsored by Istituto Ortopedico Rizzoli.

Who is sponsoring NCT06059625?

NCT06059625 is sponsored by Istituto Ortopedico Rizzoli.

What drugs are being tested in NCT06059625?

Interventions in NCT06059625: rotatori cuff repair.

What condition does NCT06059625 study?

NCT06059625 studies Cuff Injury, Rotator.

Is NCT06059625 still recruiting?

NCT06059625 is currently completed. Last updated 18 June 2024.

Last reviewed 2024-06-18 · How we verify

NCT06059625

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

RECURRENCE OF ROTATOR CUFF LESION AFTER SURGICAL REPAIR WITH SINGLE-ROW vs DOUBLE-ROW SUTURE BRIDGE TECNIQUE: A COMPARATIVE STUDY

Completed NA Last updated 18 June 2024

What this trial tests

NA trial testing rotatori cuff repair in Cuff Injury, Rotator in 30 participants. Completed in 31 May 2024.

Timeline

14 April 2021

Primary endpoint
31 May 2024

31 May 2024

Quick facts

Lead sponsor	Istituto Ortopedico Rizzoli
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	30
Start date	14 April 2021
Primary completion	31 May 2024
Estimated completion	31 May 2024
Sites	1 location across Italy

Drugs / interventions tested

rotatori cuff repair

Conditions studied

Cuff Injury, Rotator — all drugs for Cuff Injury, Rotator →

Sponsor

Istituto Ortopedico Rizzoli — full company profile →

Who can join

Adults 45 to 75, any sex, with Cuff Injury, Rotator. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The rotator cuff is a muscle-tendon complex consisting of the tendons of the supraspinatus, subspinatus, subscapularis, and small round muscles capable of allowing movement of the shoulder joint in the various planes of space and stabilizing the glenohumeral joint. Rotator cuff tendon injuries are very common. In most cases, these injuries are mostly degenerative based, as they are related to the aging process of the individual. However, it is increasingly common to diagnose such injuries in young individuals as well. The reported incidence of rotator cuff injuries ranges from 5% to 40%, and of course the prevalence increases with age until it reaches 51% in patients older than 80 years. The diagnosis of rotator cuff injury is made based on clinical examination and instrumental investigations such as Nuclear Magnetic Resonance Imaging (MRI). Rotator cuff repair involves the use of anchors with included suture threads that allow the tendons to be returned to the level of the anatomical insertion, called the footprint. Suture technique varies depending on the extent of injury and tendon and bone quality. Single-row (single row) or double-row suture bridge (double-row suture bridge) anchoring techniques are currently a hotly debated topic in the literature.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Istituto Ortopedico Rizzoli trials

Trials by the same sponsor.

NCT07590882 — Evaluation of Return to Sports Activity After Periacetabular Osteotomy: An Observational Study · enrolling by invitation
NCT07021222 — Multifactorial Strategies for the Prevention of the Risks of Ulceration in Patients Affected by Diabetic Foot (DARE-DiaF · NA · recruiting
NCT07360964 — Clear Cell Chondrosarcoma in Italy · NA · active not recruiting
NCT07140367 — "Transarterial Microembolization (TAME) in Inflammatory Knee Pathology" · recruiting
NCT07102875 — Ready to Sail 2: A Pilot Study of Sail-Assisted Telerehabilitation in Rare Skeletal Diseases · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06059625 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istituto Ortopedico Rizzoli
Last refreshed: 18 June 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06059625.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing